Listening to Mark's interview again.... I missed the bold
Listening to Mark's interview again.... I missed the bold part of the statement below. It is a BIG deal. I can wait out an investment. There is no risk of a r/s or anything of that nature. And no TALK of it anymore on that other POS board. PPS will go up and down, but we are solid and just waiting for what we KNOW is out there and coming to us soon.
"We've steadied the company at the current market price and about to come out this year with some great revenues."
Also
"There is NO OTHER IPR that can happen at this point"
1
Zerify Inc (ZRFY) Stock Research Links
"What I am is the show stopper", "The best there is, the best there was and the best there ever will be."
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
DC Renovation and Remodeling Celebrated for Client Satisfaction DC Renovation and Remodeling has achieved noteworthy recognition from Find Local Contractors, being named a Top Client Rated Kitchen and Basement Renovation Contractor. This accolade is based on the company’s impressive five-star reviews from delighted customers, illustrating their dedication to exceptional...
Continue Reading
Neuronetics' Impressive Financial Growth in Q2 2025 Neuronetics, Inc., a leader in neurohealth technology, announced its financial and operational achievements for the second quarter of 2025, showcasing remarkable results that signal a new era of success for the company. Quarterly Highlights and Financial Performance During the second quarter of 2025, Neuronetics reported...
Continue Reading
Insight Into Lemonade's Market Short Interest Lemonade's LMND short interest has increased recently, reflecting growing market observations. The latest reports indicate that there are approximately 17.65 million shorted shares, equating to about 31.95% of the total available shares for trading. With current trading volumes in mind, it would take traders roughly 7.63 days...
Continue Reading
SkinVision Pro: Bridging Gaps in Dermatology There's a new sheriff in town for dermatology, and it's the SkinVision Pro. Launched at the HLTH Europe, this AI-powered platform is stepping up to modernize how skin health is managed globally. As skin cancer runs rampant with statistics that could send chills down anyone's spine, patient-doctor skin health communication...
Continue Reading
Lucid Group, the electric vehicle manufacturer, faced a harsh reality check back in 2024 when it announced an operational loss that came in way over estimates—between $765 million and $790 million for Q3. Just to put that into perspective, analysts were bracing for a loss of around $751.65 million, but Lucid threw them a curveball. The result? A 12% drop in its stock...
Continue Reading
